Showing results (661-670 of 916) with videos related to

Sort By:
Pageof 92
JACC. Cardiovascular Imaging|February 8, 2018
Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase InhibitorClaudia Calcagno, Olivier Lairez, Julie Hawkins, et al.
JACC. Cardiovascular Imaging|January 12, 2015
Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humansHamed Emami, Parmanand Singh, Megan MacNabb, et al.
Bioconjugate Chemistry|February 5, 2015
HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesBrenda L Sanchez-Gaytan, Francois Fay, Mark E Lobatto, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 30, 2021
Types of myocardial injury and mid-term outcomes in patients with COVID-19Annapoorna Kini, Davide Cao, Matteo Nardin, et al.
American Heart Journal|January 25, 2008
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) TrialMichael E Farkouh, George Dangas, Martin B Leon, et al.
Circulation|June 15, 2016
Household Fuel Use and Cardiovascular Disease Mortality: Golestan Cohort StudySumeet S Mitter, Rajesh Vedanthan, Farhad Islami, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 3, 2011
Evaluation of right ventricular function and post-operative findings using cardiac computed tomography in patients with left ventricular assist devicesAna Garcia-Alvarez, Leticia Fernandez-Friera, Joe F Lau, et al.
Journal of the American College of Cardiology|March 18, 2008
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosisBorja Ibanez, Gemma Vilahur, Giovanni Cimmino, et al.
Circulation|June 3, 2010
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialPeter B Berger, Deepak L Bhatt, Valentin Fuster, et al.
Plos One|December 17, 2020
Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery diseaseNaotaka Okamoto, Yuliya Vengrenyuk, Valentin Fuster, et al.
Pageof 92